Abstract
Introduction: The use of tranexamic acid (TXA) to help reduce bleeding or blood transfusions is widely acknowledged, with NICE [1] NICE guideline Blood Transfusion 2015, https://www.nice.org.uk/guidance/ng24 Google Scholar recommending that TXA is offered to all adult patients undergoing surgery, where moderate blood loss is expected. In addition the WOMAN [2] Woman trial collaborators. Effect of early tranexamic acid administration on mortality,hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international randomised, double-blind, placebo-controlled trial. Lancet 2017;389:2105-16 Google Scholar trial also supports its use within the obstetric population, for patients with postpartum haemorrhage. As part of development of our enhanced recovery protocol for elective caesarean patients, we decided to introduce routine administration of TXA, 1g intravenous dose at cord clamping, for all eligible patients, from 1 January 2018.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
